Boston Pharma Taps Ex-Catabasis Exec as CFO

Xconomy Boston — 

Boston Pharmaceuticals has named ex-Catabasis Pharmaceuticals (NASDAQ: CATB) chief financial officer Ian Sanderson, a one-time pharmaceuticals analyst at Cowen and Co., its new CFO. Boston Pharma was formed last year with a $600 million bankroll and is chaired by former Sanofi CEO Chris Viehbacher and headed by Robert Armstrong, a former executive at Eli Lilly’s Chorus incubator.